Brian Casey and Wayne Forrest[email protected]Clinical NewsPull linear MRI contrast from market, European group saysIn a stunning development, a European Union regulatory body on Friday recommended that four gadolinium-based contrast agents for MRI scans be pulled off the market due to concerns about gadolinium remaining in the body years after scans occur. The agents affected include some of the most widely used contrast products in medical imaging.March 9, 2017Page 1 of 1Top StoriesMolecular ImagingDublin team evaluates radiation dose in PSMA PET/CTReducing average injected dose and uptake time in prostate-specific membrane antigen (PSMA) PET/CT can lead to improved patient throughput, according to Irish researchers.CTBelgium moves ahead with novel radiology referral schemeCTAssessing CT image quality: Which method is best?CTCT pearls from Ireland’s top orthopedic hospitalMolecular ImagingSPECT/CT identifies prostate cancer patients with poor outcomes
